Lisata Therapeutics Inc. (LSTA) — Cash Flow Reinvestment Rate

Latest as of June 2020: 0.00x

Lisata Therapeutics Inc. (LSTA) has a Cash Flow Reinvestment Rate of 0.00x as of June 2020, reinvesting $12.00K (capex $12.00K ) from operating cash flow of $4.50 Million. Check Lisata Therapeutics Inc. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$12.00K
Capex + Investments

Operating Cash Flow

$4.50 Million
USD

Capital Expenditures

$12.00K
USD

Lisata Therapeutics Inc. Cash Flow Reinvestment Rate (1992–2002)

Historical reinvestment intensity for Lisata Therapeutics Inc. across 3 annual periods. Explore Lisata Therapeutics Inc. long-term investment intensity to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Lisata Therapeutics Inc. (1992–2002)

Year-by-year capital reinvestment analysis for Lisata Therapeutics Inc.. For live market cap and broader valuation context, see Lisata Therapeutics Inc. (LSTA) market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2002 0.00x $1.13K $1.01 Million $1.13K ▼ -99.9%
1993 1.06x $500.00K $470.00K $500.00K ▲ +219.1%
1992 0.33x $80.00K $240.00K $80.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow